- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | What's Driving Optimism Around Coterra Energy Inc. (CTRA) | ||
| Di | Oppenheimer Calls KBR, Inc. (KBR) an "Interesting Value-Based Investment Opportunity" | ||
| Di | Wall Street Mixed on PG&E Corporation (PCG) as Growth Opportunities Emerge for 2026 | ||
| Di | 14 Best Dividend Aristocrats to Invest in Heading into 2026 | ||
| Di | 10 Hottest Large-Cap Stocks of 2025 | ||
| Di | DigitalBridge (DBRG) Soars 9.7% on $4-Billion SoftBank Merger | ||
| Di | NIO (NIO) Soars 4.7% on Robust Preliminary Q4 Sales | ||
| Di | Blue Owl (OTF) Soars Ahead of Dividend Payout | ||
| Di | Peloton (PTON) Regains 3.5% on Holiday Pickup | ||
| Di | D-Wave (QBTS) Climbs 3.4% on Window-Dressing | ||
| Di | Micron Technology (MU) Soars to All-Time High Ahead of Dividend Payout | ||
| Di | Bath & Body Works (BBWI) Climbs 3% on Holiday Boost | ||
| Di | Applied Digital (APLD) Jumps 3% on Cloud Business Spinoff | ||
| Di | Do You Believe in the Growth Potential of Warner Bros. Discovery (WBD)? | ||
| Di | Contrarius Global Equity Fund's Thoughts on Paramount Skydance Corporation (PSKY) | ||
| Di | Contrarius Global Equity Fund Believes Tesla (TSLA) Remains an Extremely Undervalued Stock | ||
| Di | Contrarius Global Equity Fund's Thoughts on CRISPR Therapeutics' (CRSP) Gene Editing Therapy | ||
| Di | What Makes Intellia Therapeutics (NTLA) an Interesting Investment? | ||
| Di | Do You Think Beam Therapeutics (BEAM) is an Undervalued Stock? | ||
| Di | Uranium Energy Corporation (UEC) Rallied 130% Post Purchase | ||
| Di | Should You Consider Adding Lemonade (LMND) to Your Portfolio? | ||
| Di | Hims & Hers Health (HIMS) Fell Due to Increased Regulatory Challenges | ||
| Di | Klarna Group (KLAR) Collaborates With Coinbase for Stablecoin Funding | ||
| Di | BofA Maintains a Buy Recommendation on Affirm Holdings (AFRM) | ||
| Di | Block, Inc. (XYZ)'s Square and Thrive Expand Partnership |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .